BioSpace News Archive

Business

Compugen Announces the Appointment of New Board Members

Compugen, a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the appointment of three new members to its Board of Directors

June 11, 2018
·
7 min read
Business

MaxCyte and U.S. National Institutes of Health’s National Heart, Lung, and Blood Institute Enter Cooperative Research & Development Agreement for Sickle Cell Disease

Under this agreement, MaxCyte’s second signed with a U.S. NIH institute in the past year, the Company and the National Heart, Lung, and Blood Institute will explore development of new therapies for sickle cell disease using MaxCyte’s gene-correction platform

June 11, 2018
·
3 min read
Business

Translate Bio Announces Agreement with Sanofi Pasteur to Develop Vaccines for Infectious Diseases using Novel mRNA Technology

Translate Bio announced today a multi-year research and development collaboration and exclusive licensing agreement with Sanofi Pasteur.

June 11, 2018
·
5 min read
Biotech Bay

Brain-Machine Interface Company Paradromics Secures a $7 Million Series Seed Led by Arkitekt Ventures

Paradromics Inc., today announced that it has completed a $7 million Seed round of financing.

June 11, 2018
·
2 min read
Drug Development

Can-Fite Reports on New Pre-Clinical Developments with Its NASH Drug Namodenoson

Can-Fite BioPharma Ltd. today provided an update on new pre-clinical data supporting the selection of the primary endpoint for the current ongoing Phase II study in NAFLD/NASH patients.

June 11, 2018
·
7 min read
Policy

AgeX Therapeutics Closes on $5 Million Strategic Investment From Juvenescence

AgeX Therapeutics, Inc. today announced that it has closed a $5 million equity financing, through the sale of two million AgeX common shares to Juvenescence Ltd.

June 11, 2018
·
6 min read
Policy

The UK National Institute For Health And Care Excellence To Undertake A Partial Review Of The ILUVIEN Reimbursement Guidance Allowing Broader Availability

More patients in England and Wales with chronic DME could benefit from low-dose corticosteroid intravitreal implant that lasts up to three years

June 11, 2018
·
6 min read
Business

Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update

Rubin succeeds Paul Geyer, who will remain a Director of the Board.

June 11, 2018
·
11 min read
FDA

Arcus Biosciences Announces FDA Clearance of INDs for AB928 and AB122 and Initiation of Phase 1/1b Program to Evaluate AB928 Combinations

Phase 1/1b trial to evaluate the safety, tolerability and preliminary efficacy in patients with breast and gynecologic malignancies.

June 11, 2018
·
6 min read
Business

Alexion and Complement Pharma Announce Partnership to Co-Develop Pre-Clinical Complement Inhibitor for Neurodegenerative Disorders

Collaboration provides opportunity to expand on Alexion’s two decades of complement leadership

June 11, 2018
·
6 min read